Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis

Most anti-angiogenic therapies currently being evaluated target the vascular endothelial growth factor (VEGF) pathway; however, the tumor vasculature can acquire resistance to VEGF-targeted therapy by shifting to other angiogenesis mechanisms. Therefore, other therapeutic agents that block non-VEGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guang-Wei, Jiang, Jin-Song, Lu, Wei-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632735/
https://www.ncbi.nlm.nih.gov/pubmed/26473837
http://dx.doi.org/10.3390/ijms161024011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632735/
https://www.ncbi.nlm.nih.gov/pubmed/26473837
http://dx.doi.org/10.3390/ijms161024011

Ejemplares similares